GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipum AB (OSTO:LIPUM) » Definitions » Cash Flow from Others

Lipum AB (OSTO:LIPUM) Cash Flow from Others : kr0.11 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Lipum AB Cash Flow from Others?

Lipum AB's cash flow from others for the three months ended in Dec. 2024 was kr0.11 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.11 Mil.

Lipum AB Cash Flow from Others Historical Data

The historical data trend for Lipum AB's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipum AB Cash Flow from Others Chart

Lipum AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Others
Get a 7-Day Free Trial - 0.09 0.09 0.10 0.11

Lipum AB Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 - - - 0.11

Lipum AB Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.11 Mil.

Lipum AB Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Lipum AB's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.

Lipum AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipum AB (OSTO:LIPUM) » Definitions » Cash Flow from Others
Comparable Companies
XSAT:CESSA OSTO:IVACC OSTO:ISOFOL OSTO:ACE OSTO:XBRANE OSTO:XINT OSTO:IRLAB A OSTO:INIT OSTO:GUARD OSTO:IMMU VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Tvistevagen 48 C, Umea, SWE, 907 36
Website
https://www.lipum.se
Lipum AB is a clinical-stage biopharmaceutical company specializing in the discovery and development of a novel treatment for chronic inflammatory diseases. The candidate SOL-116 is a humanized antibody designed to provide efficacious therapy by blocking a previously overlooked target molecule (BSSL) of the immune system. The development is supported by solid pre-clinical data for rheumatoid arthritis. Lipum also explores other inflammatory diseases with a high unmet medical need.

Lipum AB Headlines

No Headlines